Publications by authors named "David Diuguid"

Claim this Profile
C
Case Report: A Unique Case of Hemophagocytic Lymphohistiocytosis in Heart Transplant.
Boaz Elad, Wojciech Rzechorzek, Kelly Axsom, Justin Fried, Farhana Latif, David L Diuguid

Transplant Proc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary.
Deborah M Siegal, Eric K Tseng, Holger J Schünemann, Pantep Angchaisuksiri, Adam Cuker, David Diuguid

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients.
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, David Diuguid

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients.
Adam Cuker, Eric K Tseng, Holger J Schünemann, Pantep Angchaisuksiri, Clifton Blair, David Diuguid

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis.
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, David Diuguid

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients.
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, David Diuguid

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19.
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, Pantep Angchaisuksiri, Clifton Blair, David Diuguid

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy.
Elizabeth F Stone, Scott T Avecilla, David L Wuest, Christine Lomas-Francis, Connie M Westhoff, David L Diuguid

Haematologica· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Elliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, Russell E Ware, Videlis Nduba, David L Diuguid

N Engl J Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
Chia-Ling Lee, Paolo C Colombo, Andrew Eisenberger, David Diuguid, Douglas L Jennings

Ann Thorac Surg· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clotting and Bleeding in Oncology Patients: Clinical Scenarios and Challenges.
Kimberly M Komatsubara, David L Diuguid

Oncology (Williston Park)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Daryl Glick, Amy L Dzierba, Darryl Abrams, Justin Muir, Andrew Eisenberger, David Diuguid

J Crit Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices.
Justin Fried, Allison P Levin, Kanika M Mody, Arthur R Garan, Melana Yuzefpolsakaya, David L Diuguid

J Heart Lung Transplant· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A severe case of cefoxitin-induced immune hemolytic anemia.
David E Leaf, Nathaniel B Langer, Mark Markowski, George Garratty, David L Diuguid

Acta Haematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worth a second look.
David Goldberg, Ilan Weisberg, David Diuguid, Paul Gaglio, Bachir Alobeid

Am J Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient.
Luci Leykum, Jacqueline Pugh, David Diuguid, Kyriakos Papadopoulos

J Hosp Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Off-pump right atrial thrombectomy for heparin-induced thrombocytopenia with thrombosis.
Jeffrey A Morgan, Aftab R Kherani, Deon W Vigilance, Faisal H Cheema, Nicholas J Colletti, David L Diuguid

Ann Thorac Surg· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis